PMID: 42119587

Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial.

Horn Deborah B, Aronne Louis J, Wharton Sean, Bays Harold E, le Roux Carel W, Srinath Reshmi, Gomez-Valderas Elisa, Arad Avigdor D, Das Sagar, Dunn Julia P

Lancet (London, England) · 2026

This entry links to third-party literature. For research use only.